Page 173 - Technology Platform News Today

SoFi Technologies (NASDAQ:SOFI – Get Rating) is one of 71 public companies in the “Nondepository credit institutions” industry, but how does it compare to its competitors? We will compare SoFi Technologies to related companies based on the strength of its analyst recommendations, dividends, institutional ownership, valuation, risk, profitability and earnings. Profitability This table compares SoFi […]

Equities research analysts expect that REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) will announce earnings of ($1.57) per share for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for REGENXBIO’s earnings, with estimates ranging from ($1.60) to ($1.56). REGENXBIO posted earnings of ($1.36) per share in the same quarter last year, which would […]

SoFi Technologies (NASDAQ:SOFI – Get Rating) is one of 71 public companies in the “Nondepository credit institutions” industry, but how does it compare to its peers? We will compare SoFi Technologies to related companies based on the strength of its institutional ownership, valuation, dividends, analyst recommendations, profitability, earnings and risk. Volatility and Risk SoFi Technologies […]

208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic...

SAP S/4HANA Cloud promises a superior approach to dealing with changing conditions in business processes like supply chain, according to SAPs Sven Denecken.

REGENXBIO (NASDAQ:RGNX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include […]

SoFi Technologies (NASDAQ:SOFI – Get Rating) is one of 71 public companies in the “Nondepository credit institutions” industry, but how does it contrast to its competitors? We will compare SoFi Technologies to similar companies based on the strength of its profitability, earnings, dividends, risk, analyst recommendations, institutional ownership and valuation. Insider and Institutional Ownership 56.5% […]

Several brokerages have updated their recommendations and price targets on shares of SoFi Technologies (NASDAQ: SOFI) in the last few weeks: 5/17/2022 – SoFi Technologies had its price target lowered by analysts at Mizuho from $14.00 to $9.00. They now have a “na” rating on the stock. 5/16/2022 – SoFi Technologies was upgraded by analysts […]

REGENXBIO (NASDAQ:RGNX – Get Rating) had its target price cut by equities research analysts at Morgan Stanley from $51.00 to $47.00 in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. The brokerage currently has an “overweight” rating on the biotechnology company’s stock. Morgan Stanley’s price target would suggest a […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.